Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
14%
Abiraterone
14%
Academic Achievement
28%
American Urological Association
28%
Awareness Month
14%
Benign Prostatic Hyperplasia
28%
Breast Cancer Awareness Month
14%
Cancer Awareness
14%
Clinical Practice Guidelines
21%
Clinical Trials
30%
Comparative Analysis
14%
Drug Development
14%
Emergency Medicine
14%
Exclusion Criteria
29%
Federal Funding
11%
Fellowship Training
15%
First Author
21%
Fragility Analysis
28%
Fragility Index
25%
Google Trends
14%
Hematuria
14%
Industry Funding
11%
Intervention Reporting
14%
Measurement Tool
11%
Meta-analysis
26%
Non-publication
14%
Oncology Clinical Trials
14%
Oncology Drugs
14%
Ophthalmology
14%
Otolaryngology Residency
28%
Otolaryngology Residency Programs
15%
Patient Benefit
14%
Patient Outcomes
14%
Patient Risk
19%
Peyronie's Disease
14%
Prostate Cancer
21%
PubMed
18%
Randomized Clinical Trial
14%
Randomized Controlled Trial
66%
Renal Cell Carcinoma
14%
Research Productivity
28%
Research Waste
11%
Residency
28%
Risk Outcomes
14%
Risk-benefit
14%
Total Publications
17%
Transarterial Embolization
14%
Urologic
16%
Urologic Oncology
14%
Urology
60%
Medicine and Dentistry
Adverse Event
7%
Arm
6%
Arterial Embolization
14%
Awareness
14%
Breast Cancer
14%
Checklist
8%
Clear Cell Renal Cell Carcinoma
14%
Clinical Trial
48%
Clinician
6%
Comparative Analysis
14%
Drug Efficacy
9%
Emergency Medicine
14%
Erectile Dysfunction
28%
Hematuria
14%
Meta-Analysis
33%
Neoplasm
5%
Oncology
14%
Overall Survival
16%
Peyronie's Disease
14%
Progression Free Survival
5%
Prostate Cancer
14%
Prostate Hypertrophy
42%
Randomized Controlled Trial
81%
Reproducibility
28%
Systematic Review
100%
Treatment Group
10%
Urology
89%